CHMP adopts positive opinion for variation to terms of Reyataz marketing authorization April 28, 2010 No Comments
CHMP recommends Seroquel XR as add-on treatment for major depressive disorder April 27, 2010 No Comments
Aeterna Zentaris receives advice from the EMA for phase III perifosine program April 16, 2010 No Comments
Raloxifene decreases epistaxis in hereditary hemorrhagic telangiectasia / News in Context April 13, 2010 No Comments
EMA grants orphan drug designation to Protalix's taliglucerase alfa for Gaucher's disease March 30, 2010 No Comments
RSS